617
Views
5
CrossRef citations to date
0
Altmetric
Original Research Articles

Human papillomavirus variants among Inuit women in northern Quebec, Canada

, , &
Article: 29482 | Received 19 Aug 2015, Accepted 19 Nov 2015, Published online: 09 Dec 2015

References

  • De Villiers E-M, Fauquet C, Broker TR, Bernard H-U, zur Hausen H. Classification of papillomaviruses. Virology. 2004; 324: 17–27.
  • Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine. 2006; 24: S4–15.
  • Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, etal. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189: 12–19.
  • Moscicki A-B, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, etal. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine. 2012; 30: F24–33.
  • Bernard HU, Calleja-Macias IE, Dunn ST. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer. 2006; 118: 1071–6.
  • Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez AC, etal. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst. 2001; 93: 315–18.
  • Ho L, Chan S, Burk R, Das B, Fujinaga K, Icenogle J, etal. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol. 1993; 67: 6413–23.
  • Ong C, Chan S, Campo M, Fujinaga K, Mavromara-Nazos P, Labropoulou V, etal. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol. 1993; 67: 6424–31.
  • Calleja-Macias IE, Villa LL, Prado JC, Kalantari M, Allan B, Williamson A-L, etal. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol. 2005; 79: 13630–40.
  • Raiol T, Wyant PS, de Amorim RMS, Cerqueira DM, Milanezi NvG, Brígido Mde M, etal. Genetic variability and phylogeny of the high-risk HPV-31,-33,-35,-52, and-58 in central Brazil. J Med Virol. 2009; 81: 685–92.
  • Zhang C, Park JS, Grce M, Hibbitts S, Palefsky JM, Konno R, etal. Geographical distribution and risk association of human papillomavirus genotype 52-variant lineages. J Infect Dis. 2014; 210: 1600–4.
  • Vrtačnik Bokal E, Kocjan BJ, Poljak M, Bogovac Ž, Jančar N. Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia. J Obstet Gynaecol Res. 2010; 36: 1204–13.
  • Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, etal. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010; 70: 3159–69.
  • Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, etal. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 1997; 71: 2463–72.
  • Chang YJ, Chen HC, Pan MH, Lee BH, You SL, Lin CY, etal. Intratypic variants of human papillomavirus type 16 and risk of cervical neoplasia in Taiwan. J Med Virol. 2013; 85: 1567–76.
  • Chan PK, Luk AC, Park J-S, Smith-McCune KK, Palefsky JM, Konno R, etal. Identification of human papillomavirus type 58 lineages and the distribution worldwide. J Infect Dis. 2011; 203: 1565–73.
  • Statistics Canada. Région du Nunavik, Quebec (Code2417) (table). Aboriginal Population Profile. 2006 Census. Statistics Canada Catalogue no. 92-594-XWE. Released January 15, 2008. [cited 2015 Mar 13]. Available from: http://www12.statcan.ca/census-recensement/2006/dp-pd/prof/92-594/index.cfm?Lang=E Ottawa2007.
  • Kelly J, Lanier A, Santos M, Healey S, Louchini R, Friborg J, etal. Cancer among the circumpolar Inuit, 1989–2003. II. Patterns and trends. Int J Circumpolar Health. 2008; 67: 408–20.
  • Hamlin-Douglas LK, Coutlee F, Roger M, Franco EL, Brassard P. Prevalence and age distribution of human papillomavirus infection in a population of Inuit women in Nunavik, Quebec. Cancer Epidemiol Biomarkers Prev. 2008; 17: 3141–9.
  • Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, etal. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Can Med Assoc J. 2000; 163: 503–8.
  • Vasilevska M, Ross SA, Gesink D, Fisman DN. Relative risk of cervical cancer in indigenous women in Australia, Canada, New Zealand, and the United States: a systematic review and meta-analysis. J Public Health Policy. 2012; 33: 148–64.
  • Sebbelov AM, Davidson M, Krüger Kjaer S, Jensen H, Gregoire L, Hawkins I, etal. Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians. Microbes Infect. 2000; 2: 121–6.
  • Kelly JJ, Unger ER, Dunne EF, Murphy NJ, Tiesinga J, Koller KR, etal. HPV genotypes detected in cervical cancers from Alaska Native women, 1980–2007. Int J Circumpolar Health. 2013; 72: 289–94.
  • Rodrigues-Coutlee C, Archambault J, Money D, Ramanakumar AV, Raboud J, Hankins C, etal. Human papillomavirus type 56 polymorphism in Canadian women with and without cervical lesions. J Clin Virol. 2013; 58: 660–5.
  • Cabiles D, Brassard P, Griffith A, Jiang Y, Mao T, Severini A. HPV 16 & 18 variants in aboriginal and non-aboriginal women in the Northwest Territories, Canada. The 26th International Papillomavirus Conference and Clinical Workshop, Montreal, Quebec; 2010 Jul 3..
  • Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, etal. A review of human carcinogens – Part B: biological agents. Lancet Oncol. 2009; 10: 321–2.
  • Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, etal. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer. 2007; 120: 1763–8.
  • Franco EL, Villa LL, Rahal P, Ruiz A. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. J Natl Cancer Inst. 1994; 86: 1558–9.
  • Aho J, Hankins C, Tremblay C, Forest P, Pourreaux K, Rouah F, etal. Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women. J Infect Dis. 2004; 190: 46–52.
  • Gagnon S, Hankins C, Tremblay C, Pourreaux K, Forest P, Rouah F, etal. Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infection. J Med Virol. 2005; 75: 213–21.
  • Gagnon S, Hankins C, Tremblay C, Forest P, Pourreaux K, Coutlée F, etal. Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women. J Infect Dis. 2004; 190: 1575–85.
  • Chan PK, Zhang C, Park JS, Smith-McCune KK, Palefsky JM, Giovannelli L, etal. Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations. Int J Cancer. 2013; 132: 2528–36.
  • Arias-Pulido H, Peyton CL, Torrez-Martínez N, Anderson DN, Wheeler CM. Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1regions. Virology. 2005; 338: 22–34.
  • Hamlin-Douglas LK, Coutlee F, Roger M, Hanley J, Franco EL, Brassard P. Determinants of human papillomavirus infection among Inuit women of northern Quebec, Canada. Sex Transm Dis. 2010; 37: 377–81.
  • Lopera EA, Baena A, Florez V, Montiel J, Duque C, Ramirez T, etal. Unexpected inverse correlation between Native American ancestry and Asian American variants of HPV16 in admixed Colombian cervical cancer cases. Infect Genet Evol. 2014; 28: 339–48.
  • Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, etal. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol. 2000; 81: 2959–68.
  • Xi LF, Schiffman M, Koutsky LA, Hughes JP, Winer RL, Mao C, etal. Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia. J Natl Cancer Inst. 2014; 106: dju270.
  • Xi LF, Schiffman M, Koutsky LA, He Z, Winer RL, Hulbert A, etal. Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage. Int J Cancer. 2013; 132: 549–55.
  • Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferreira S, etal. Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. J Infect Dis. 2006; 194: 886–94.
  • Chen AA, Heideman DA, Boon D, Chen Z, Burk RD, De Vuyst H, etal. Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer. Virology. 2014; 448: 356–62.
  • Chen AA, Heideman DA, Boon D, Gheit T, Snijders PJ, Tommasino M, etal. Human papillomavirus 45 genetic variation and cervical cancer risk worldwide. J Virol. 2014; 88: 4514–21.